Health TrialsbyHealthPanel

Wolff-Parkinson-White Syndrome

2

Review clinical trials related to Wolff-Parkinson-White Syndrome. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

AI-Based Differential Diagnosis and Localization of Tachycardia Using ECG: Multicenter Registry (EP-AI ASSIST)

This multicenter retrospective study aims to develop, validate, and clinically apply an artificial intelligence (AI)-powered electrocardiography (ECG) algorithm for the diagnosis and prognostic prediction of cardiovascular diseases, including coronary artery disease and heart failure. By utilizing encrypted raw 12-lead ECG text data and deep neural network models, the study evaluates the effectiveness of AI-enhanced ECG in detecting cardiac abnormalities and predicting clinical outcomes.

Participants needed: 10,000
Trial details
Age: 19+Biological sex: AllType: ObservationalSponsor: Inha University HospitalUpdated: Oct 5, 2026Locations: 1
Eligibility criteria

Patients aged 19 years or older diagnosed with tachycardias (including PSVT, WPW... [+1]

Read more
Status: Recruiting

ATR 1072 in Participants With PRKAG2 Syndrome

ATR 1072 is an investigational medicine being studied in adults with PRKAG2 Syndrome. This study will evaluate the safety of ATR 1072 and how the body processes the drug. Researchers will also assess how ATR 1072 affects PRKAG2 activity and measures of heart disease.

Participants needed: 37
Trial details
Phase: Phase 1, Phase 2Age: 18-65Biological sex: AllType: InterventionalSponsor: Atrium TherapeuticsUpdated: Sep 18, 2026Locations: 1
Eligibility criteria

Adults 18 to 65 years of age. [+4]

Pregnancy or breastfeeding. [+5]

Read more